Nathaniel Herzfeld

Array ( [id] => 9375798 [patent_doc_number] => 08680062 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-25 [patent_title] => 'System for delivering therapeutic agents into living cells and cells nuclei' [patent_app_type] => utility [patent_app_number] => 11/806609 [patent_app_country] => US [patent_app_date] => 2007-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 17 [patent_no_of_words] => 44869 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11806609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9311804 [patent_doc_number] => 08653022 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-18 [patent_title] => 'Use of ghrelin splice variant for treating hypercholesterolemia and/or high cholesterol and/or high cholesterol complication and/or lipemia and/or lipemia complication and/or coronary heart disease and/or weight management and/or diabetes and/or hyperglycemia' [patent_app_type] => utility [patent_app_number] => 12/294823 [patent_app_country] => US [patent_app_date] => 2007-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 15573 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 189 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12294823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9227495 [patent_doc_number] => 08633163 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-21 [patent_title] => 'Template-fixed peptidomimetics' [patent_app_type] => utility [patent_app_number] => 12/524862 [patent_app_country] => US [patent_app_date] => 2007-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30132 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12524862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4889524 [patent_doc_number] => 20080263689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Methods for Identifying Modulators of Protein Kinase C-Epsilon (Pkce) and Method of Treatment of Aberrant Glucose Metabolism Associated Therewith' [patent_app_type] => utility [patent_app_number] => 10/572110 [patent_app_country] => US [patent_app_date] => 2004-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 29414 [patent_no_of_claims] => 82 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20080263689.pdf [firstpage_image] =>[orig_patent_app_number] => 10572110 [rel_patent_id] =>[rel_patent_doc_number] =>)